{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:03:07Z","timestamp":1788314587978,"version":"build-2803163510"},"reference-count":6,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-024-03749-x","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T10:02:34Z","timestamp":1727431354000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Familial hypokalemic periodic paralysis: a case induced by concurrent hyperthyroidism"],"prefix":"10.1186","volume":"25","author":[{"given":"Zein Alabdin","family":"Hannouneh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Elena","family":"Cervantes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. John","family":"Sperati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"Hanouneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,27]]},"reference":[{"issue":"4","key":"3749_CR1","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/mus.26009","volume":"57","author":"JM Statland","year":"2018","unstructured":"Statland JM, et al. Review of the diagnosis and treatment of periodic paralysis. Muscle Nerve vol. 2018;57(4):522\u201330. https:\/\/doi.org\/10.1002\/mus.26009.","journal-title":"Muscle Nerve vol"},{"issue":"Pt 1","key":"3749_CR2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1093\/brain\/awh639","volume":"129","author":"SL Venance","year":"2006","unstructured":"Venance SL, Cannon SC, Fialho D, et al. The primary periodic paralyses: diagnosis, pathogenesis and treatment. Brain J Neurol. 2006;129(Pt 1):8\u201317. https:\/\/doi.org\/10.1093\/brain\/awh639.","journal-title":"Brain J Neurol"},{"issue":"18","key":"3749_CR3","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1212\/01.wnl.0000342387.65477.46","volume":"72","author":"E Matthews","year":"2009","unstructured":"Matthews E, Labrum R, Sweeney MG, et al. Voltage sensor charge loss accounts for most cases of hypokalemic periodic paralysis. Neurology. 2009;72(18):1544\u20137. https:\/\/doi.org\/10.1212\/01.wnl.0000342387.65477.46.","journal-title":"Neurology"},{"issue":"3","key":"3749_CR4","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/0014-5793(96)00173-1","volume":"382","author":"P Lapie","year":"1996","unstructured":"Lapie P, Goudet C, Nargeot J, Fontaine B, Lory P. Electrophysiological properties of the hypokalaemic periodic paralysis mutation (R528H) of the skeletal muscle alpha 1s subunit as expressed in mouse L cells. FEBS Lett. 1996;382(3):244\u20138. https:\/\/doi.org\/10.1016\/0014-5793(96)00173-1.","journal-title":"FEBS Lett"},{"issue":"13","key":"3749_CR5","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1212\/WNL.0000000000002524","volume":"86","author":"IW Song","year":"2016","unstructured":"Song IW, Sung CC, Chen CH, et al. Novel susceptibility gene for nonfamilial hypokalemic periodic paralysis. Neurology. 2016;86(13):1190\u20138. https:\/\/doi.org\/10.1212\/WNL.0000000000002524.","journal-title":"Neurology"},{"issue":"1","key":"3749_CR6","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/1531-8249(200001)47:1<46::AID-ANA9>3.0.CO;2-H","volume":"47","author":"R Tawil","year":"2000","unstructured":"Tawil R, McDermott MP, Brown R, et al. Randomized trials of dichlorphenamide in the periodic paralyses. Working Group on periodic paralysis. Ann Neurol. 2000;47(1):46\u201353.","journal-title":"Ann Neurol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-024-03749-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-024-03749-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-024-03749-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T10:06:32Z","timestamp":1727431592000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-024-03749-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,27]]},"references-count":6,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3749"],"URL":"https:\/\/doi.org\/10.1186\/s12882-024-03749-x","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,27]]},"assertion":[{"value":"12 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of their clinical details and\/or clinical images was obtained from the patient. A copy of the consent form is available for review by the Editor of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Mohamad Hanouneh reports serving on a speaker\u2019s bureau for AstraZeneca, Bayer, Alexion, and Boehringer Ingelheim. The remaining authors have nothing to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"315"}}